Determinants of HIV related mortality in African children on antiretroviral therapy: clinical and immunological insights from a systematic review and meta-analysis [0.03%]
非洲儿童接受抗逆转录病毒治疗后的人类免疫缺陷病毒感染相关死亡率的影响因素：系统评价和meta分析的临床及免疫学启示
Sisay Moges,Bereket Aberham Lajore
Sisay Moges
Background: The HIV epidemic in Africa is still a serious public health concern, particularly for children who are more vulnerable to its negative consequences. Various studies carried out in different African nations hav...
Brief communication: demographic disparities and modes of transmission of HIV in Mizoram, Northeast India [0.03%]
简讯：印度东北部米佐拉姆邦艾滋病流行特征及传播模式的差异性分析
Lalnunthari Khawlhring,Benjamin Lalrinpuia,Rebecca Lalngaihzuali et al.
Lalnunthari Khawlhring et al.
This study examines the prevalence of Human immunodeficiency virus (HIV) in Mizoram, Northeast India, with a focus on age-group transmission routes and gender-specific prevalence. According to data from the ART Plus Centre at Civil Hospital...
Antiretroviral therapy clients' experience of Follow-up care in tshwane, Gauteng province, South Africa [0.03%]
南非豪滕省茨瓦内艾滋病患者随访治疗体验研究
Kulani James Mabasa,Sibusiso Zuma
Kulani James Mabasa
Background: Access to antiretroviral therapy (ART) has improved substantially in resource-limited settings in Africa, Asia, and South America, where 90% of people living with human immunodeficiency virus and acquired immu...
Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options [0.03%]
卡姆eroon接受抗逆转录病毒治疗失败患者的获得性HIV-1药物耐药及其对今后治疗方案的影响
Joseph Fokam,Tekoh Tatiana Anim-Keng,Benjamin Thumamo Pokam et al.
Joseph Fokam et al.
HIV-1 drug resistance (HIVDR) surveillance among individuals failing antiretroviral therapy (ART) is essential to selecting optimal ART-combinations for use in a public health approach in low-middle-income countries (LMICs) where routine HI...
Prevalence of vitamin B12 deficiency, associated factors, and correlation with CD4 count among HIV-positive adults at Kayunga Regional Referral Hospital, Central Uganda [0.03%]
乌干达中部Kayunga地区转诊医院HIV阳性成人维生素B12缺乏患病率、相关因素及与CD4计数的相关性
Mohamed Jayte,Mai Abdalla Ali,Abdifatah Hersi Karshe et al.
Mohamed Jayte et al.
Background: Vitamin B12 deficiency is a common but under-recognized comorbidity among HIV-infected individuals, contributing to anemia, neurological impairment, and poor immune recovery. In sub-Saharan Africa, where HIV b...
Metagenomic next-generation sequencing for pathogen detection of pulmonary infections in persons living with HIV [0.03%]
HIV感染者肺部感染病原体的宏基因组高通量测序检测研究
Yapeng Zhang,Shaowei Guo,Lihua Lu et al.
Yapeng Zhang et al.
Background: This study aimed to evaluate the diagnostic utility of metagenomic next-generation sequencing (mNGS) in detecting pulmonary infections in persons living with HIV(PLWH). ...
The association of antiretroviral therapy type and duration of use with stroke in people living with HIV in Zambia [0.03%]
赞比亚HIV感染者中抗逆转录病毒治疗类型和用药时长与脑卒中的关联性研究
Stanley Zimba,Owen Ngalamika,Emmanuel Mukambo et al.
Stanley Zimba et al.
Background: People living with HIV (PLWH) are at increased risk of stroke due to many factors including possibly antiretroviral therapy (ART) use. We sought to evaluate the association between ART type and duration of use...
High HIV viral suppression among adults receiving WHO-recommended first-line dolutegravir-based antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis of programmatic evidence [0.03%]
低收入和中等收入国家接受世界卫生组织推荐的一线多替拉韦抗逆转录病毒治疗的成人HIV高病毒抑制率：基于项目管理证据的系统综述和荟萃分析
Amalia Girón-Callejas,Rolando Lorenzana,Michael Pickles et al.
Amalia Girón-Callejas et al.
Background: This systematic review and meta-analysis assessed viral suppression among adults receiving WHO-recommended first-line dolutegravir-based ART in programmatic settings in low- and middle-income countries (LMICs)...
Allan Buzibye,Barbara Castelnuovo,Robert C Bollinger et al.
Allan Buzibye et al.
Dolutegravir is a preferred antiretroviral drug given its high resistance barrier and efficacy; however, reports from sub-Saharan Africa indicate increased hyperglycemia rates among individuals living with HIV on dolutegravir. Potential mec...
Clinical outcomes on B/F/TAF and dolutegravir-based regimens at 12 months following regimen switch: an observational cohort study [0.03%]
一项观察性队列研究：换药1年后基于B/F/TAF和多替拉韦方案的临床结果（第12个月）
Paul E Sax,Janna Radtchenko,Megan Dunbar et al.
Paul E Sax et al.
Background: This retrospective observational study evaluated the clinical use and treatment outcomes in virologically suppressed people with HIV (PWH) switching to either bictegravir/emtricitabine/tenofovir alafenamide (B...
Observational Study
AIDS research and therapy. 2025 Sep 26;22(1):90. DOI:10.1186/s12981-025-00789-7 2025